Category: Uncategorized

LifETIME CDT Student Day

By LifETIME CDT Administrator: Emma Lardner (University of Birmingham) Delegates have attended the first virtual LifETIME CDT Student Day event bringing together academics, industry partners and LifETIME students. The event began with a welcome from Ivan Wall, Professor of Regenerative Medicine, Cell & Gene Therapy Bioprocessing at Aston University who gave an informative overview of the

FLIM starring metastatic pancreatic cancer cells

By LifETIME CDT Student: Elena Mandrou (University of Glasgow) My project revolves around studying a signalling pathway that previous research showed it is important for the directional metastasis (or spread) of aggressive cancers.  The signal in question is a lipid called lysophosphatidic acid (or LPA) that exists in the cells’ surroundings. The cells’ have a

lifETIME goes to “Future Leaders in Regenerative Medicine: Joint Conference CDTs and UKSB”

By LifETIME CDT Student: Lydia-Styliani Marinou (University of Glasgow) Once upon a time, the Lifetime CDT collaborated with the following CDTs and the UK Society of Biomaterials to organise a joint event this summer:  EPSRC-SFI Joint CDT in Engineered Tissues for Discovery, Industry and Medicine (LifETIME) EPSRC/MRC CDT in Regenerative Medicine EPSRC/MRC CDT in Regenerative

Dragons Den Competition

By LifETIME CDT Student: Megan Boseley (Aston University) As part of the CDT coronavirus online training the Dragons Den competition, including the 5 preliminary business and marketing sessions, were pushed forward and moved to zoom. Initially, informative training with Peter Childs and Frank Rinaldi provided background on market awareness, IP, spin-outs and start-ups, forming a

Are 3D models the future for researching colorectal cancer?

By LifETIME CDT Student: Eileen Reidy (NUI Galway) Introduction: Colorectal cancer is one of the leading causes of cancer related deaths. Currently patients diagnosed with advanced colorectal cancer have poor 5-year survival rates. Surgery and/or chemotherapy often do not benefit these patients. Due to the complexity and diversity of late stage colorectal cancer, the effects

LifETIME CDT Adapts to Lockdown

By Michelle Carmichael (LifETIME CDT Coordinator) Due to the COVID-19 pandemic we have been living in unprecedented times for the last 14 weeks. The LifETIME CDT management team have worked together during this time to ensure that the CDT students continue with their skills training programme and continue to grow as a cohort. This blog

1 2 3 4